Topiramate
- Product NDC
- 50090-4614
- 11-digit product format
- 500904614
- Labeler code
- 50090
- Product ID
- 50090-4614_3c2cea8a-2805-4919-80f5-0bb2a6d12229
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Topiramate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076343
- Marketing category
- ANDA
- Marketing start
- 2014-06-12
- Substance
- TOPIRAMATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Topiramate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TOPIRAMATE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0H73WJJ391 |
| Rxcui | 199888 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-4614-0 | Topiramate | 60 in 1 BOTTLE | TABLET | 60 | | 10 |
| 50090-4614-1 | Topiramate | 90 in 1 BOTTLE | TABLET | 90 | | 10 |
| 50090-4614-2 | Topiramate | 30 in 1 BOTTLE | TABLET | 30 | | 10 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-4614-0 | 50090461400 | 60 TABLET in 1 BOTTLE (50090-4614-0) | 60 tablet | 2019-10-16 | 0000-00-00 | No | No | Current |
| 50090-4614-1 | 50090461401 | 90 TABLET in 1 BOTTLE (50090-4614-1) | 90 tablet | 2019-10-16 | 0000-00-00 | No | No | Current |
| 50090-4614-2 | 50090461402 | 30 TABLET in 1 BOTTLE (50090-4614-2) | 30 tablet | 2019-10-16 | 0000-00-00 | No | No | Current |